Erythromycin Tablet, Delayed Release
Product Images NDC 51407-854

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 51407-854). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-853-30ol (Erythromycin DR Tablets)

Label for Erythromycin delayed-release tablets, USP, 250 mg strength, containing 30 tablets. The label includes the NDC 51407-853-30 and states the product is Rx only. It is marketed by Golden State Medical Supply, Inc. Storage instructions and usage warnings are also provided on the label.*

FDA Label Image

51407-854-30ol (Erythromycin DR Tablets)

Label for Erythromycin Delayed-Release Tablets, USP 500 mg by Golden State Medical Supply, Inc. The label indicates the package contains 30 tablets with a strength of 500 mg each. It includes storage instructions, safety warnings, and a barcode. The label is marked Rx Only and specifies that each tablet contains erythromycin as the active ingredient.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of erythromycin, showing the molecular arrangement of atoms including oxygen, carbon, hydrogen, and nitrogen in the compound.*

FDA Label Image

Torrentlogo (Torrentlogo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.